Subscribe free

Newsletter

Upper Gastrointestinal Tract

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Ann Surg7 Dec 2023

Thoracic duct resection does not improve survival in patients with esophageal cancer

Thoracic duct (td) resection does not improve the prognosis of patients with esophageal cancer, according to a study analyzing 12,237 patients who underwent esophagectomy between 2007 and 2012 in Japan. The study found that td-resected patients had similar overall survival and cause-specific survival rates compared…

Ann Surg Oncol5 Dec 2023

Outcomes of Esophagectomy in Elderly Patients with Esophageal Cancer

Analyzing 120 elderly esophageal cancer patients (Stage I-IV), the study revealed a 5-year overall survival rate of 45.2%. Lower body mass index, reduced pre-albumin levels, advanced tumor stage, postoperative pulmonary issues, and specific treatments significantly influenced outcomes. Despite a median 31-month follow-up, esophagectomy proved safe…

Ann Surg Oncol5 Dec 2023

Optimal Timing for Gastric Cancer Surgery: Impact on Lymph Node Upstaging and Survival

Analyzing clinically node-negative gastric cancer patients, the study investigated the influence of time from diagnosis to surgery. Among 1824 patients, those with a longer interval (≥ 8 weeks) experienced less lymph node upstaging. Although overall survival differences appeared in Kaplan-Meier curves, multivariable analysis didn't associate…

BMC Surg5 Dec 2023

Innovative Imaging for Anastomotic Site Assessment in Esophagectomy

In a prospective study on esophageal cancer patients undergoing thoracic esophagectomy, researchers compared tissue oxygen saturation and indocyanine green measurements. Tissue oxygen saturation imaging proved valuable in identifying the anastomotic site, overcoming limitations of indocyanine green. In 57 patients, decreased tissue oxygen saturation at the…

Ann Surg Oncol4 Dec 2023

Resecting M1 Lymph Nodes Improves Outcomes in Advanced Esophageal Carcinoma

Examining 682 esophageal carcinoma cases, researchers found resecting metastatic lymph nodes (rm1ln) in stage IVB, especially in specific locations, showed feasibility and improved overall survival without compromising short-term safety. Notably, patients with rm1ln metastasis who underwent curative surgery demonstrated comparable short-term outcomes and overall survival…

Ann Surg Oncol3 Dec 2023

Optimal Lymph Node Removal Improves Survival in Gastric Signet-Ring Cell Cancer

Analyzing 1020 patients with gastric signet-ring cell cancer (GSRCC), researchers investigated the relationship between the number of examined lymph nodes (ELNs) and prognosis. X-tile analysis determined the optimal ELN cutoff as 22. Patients with more than 22 ELNs demonstrated higher 5-year overall survival (66.9% vs.…

Ann Surg Oncol3 Dec 2023

Radiomic Model Enhances Gastric Cancer Prognostic Prediction After Neoadjuvant Chemotherapy

A cohort study involving 205 gastric adenocarcinoma patients treated with neoadjuvant chemotherapy aimed to improve prognosis prediction. The developed radiomic model, incorporating pre- and post-treatment features, outperformed pathological T stage models. The final radiomic model, integrating radiomic and clinicopathological data, demonstrated superior accuracy in predicting…